Pre-treatment neutrophil-to-lymphocyte ratio predicts tumor pathology in newly diagnosed renal tumors
- 6 April 2016
- journal article
- research article
- Published by Springer Science and Business Media LLC in World Journal of Urology
- Vol. 34 (12), 1693-1699
- https://doi.org/10.1007/s00345-016-1821-7
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- A Review of Contemporary Data on Surgically Resected Renal Masses—Benign or Malignant?Urology, 2013
- Clinical variables for predicting metastatic renal cell carcinoma patients who might not benefit from cytoreductive nephrectomy: neutrophil-to-lymphocyte ratio and performance statusInternational Journal of Clinical Oncology, 2013
- Solitary solid renal mass: can we predict malignancy?BJU International, 2012
- Nox4 Mediates Renal Cell Carcinoma Cell Invasion through Hypoxia-Induced Interleukin 6- and 8- ProductionPLOS ONE, 2012
- Anatomic Features of Enhancing Renal Masses Predict Malignant and High-Grade Pathology: A Preoperative Nomogram Using the RENAL Nephrometry ScoreEuropean Urology, 2011
- Immunity, Inflammation, and CancerCell, 2010
- Tumor Size is Associated With Malignant Potential in Renal Cell Carcinoma CasesJournal of Urology, 2009
- Cancer-related inflammationNature, 2008
- Rising Incidence of Small Renal Masses: A Need to Reassess Treatment EffectJNCI Journal of the National Cancer Institute, 2006
- Guidelines for the evaluation of blood cell analysers including those used for differential leucocyte and reticulocyte counting and cell marker applicationsClinical and Laboratory Haematology, 1994